Nuuvera Inc. (V:NUU)
Business Focus: N/A
Apr 04, 2018 08:00 am ET
Vogogo Inc. Announces Appointment of Its New Chief Financial Officer
CALGARY, Alberta, April 04, 2018 (GLOBE NEWSWIRE) -- Vogogo Inc. (“Vogogo” or the “Company”) (CSE:VGO) is pleased to announce that, effective today, Jordan Greenberg has joined the Company as its Chief Financial Officer.
Mar 23, 2018 10:31 am ET
Aphria and Nuuvera Announce Closing Of Arrangement
/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
Mar 20, 2018 05:47 pm ET
Nuuvera announces shareholder approval of plan of arrangement with Aphria Inc.
/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
Mar 19, 2018 02:00 pm ET
Horizons ETFs Completes Rebalance of its Marijuana Life Sciences Index ETF
HMMJ adds 10 new stocks as part of this latest quarterly rebalancing
Mar 01, 2018 07:30 am ET
Nuuvera completes acquisition of remaining interest in ARA-Avanti Rx Analytics Inc.
TORONTO, March 1, 2018 /CNW/ - Nuuvera Inc. (the "Company" or "Nuuvera") (TSXV: NUU), is pleased to announce that further to its press releases on February 20, 2018 and February 22, 2018, the Company, through its subsidiaries, has completed the previously announced acquisition of the remaining 49% minority interest of ARA-Avanti Rx Analytics Inc. ("Avanti"), a subsidiary of the Company, from a single minority shareholder.
Feb 27, 2018 07:00 am ET
Nuuvera Acquires GMP Laboratory in Malta
Sets stage for servicing EU medical cannabis market
Feb 26, 2018 07:00 am ET
Nuuvera Signs Offtake Agreement with Major African Licensed Grower
Agreement with Verve Dynamics to guarantee Nuuvera access to high quality, low cost GMP cannabis extracts
Feb 22, 2018 08:00 am ET
Nuuvera enters into definitive agreement to acquire remaining interest in ARA-Avanti Rx Analytics Inc.
TORONTO, Feb. 22, 2018 /CNW/ - Nuuvera Inc. (the "Company" or "Nuuvera") (TSXV: NUU), is pleased to announce that further to its press release on February 20, 2018, Nuuvera, through its subsidiaries, has entered into a definitive share purchase agreement (the "Agreement") to acquire the remaining 49% minority interest of ARA-Avanti Rx Analytics Inc. ("Avanti"), a subsidiary of the Company, from a single minority shareholder. As part of the acquisition, Avanti has been granted an option, exercisable for 60 days following the closing of the share purchase, to purchase Avanti's facility (the "F
Feb 20, 2018 06:59 am ET
Nuuvera amends arrangement; agrees to acquire remaining interest in Avanti Rx Analytics Inc.
/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
Feb 14, 2018 08:46 am ET
Nuuvera Inc. Closes $52 Million Bought Deal Public Offering
/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
Feb 02, 2018 10:16 am ET
IIROC Trade Resumption - Nuuvera Inc.
Vancouver, British Columbia--(Newsfile Corp. - February 2, 2018) - Trading resumes in:
Feb 02, 2018 09:58 am ET
IIROC Trade Halt - Nuuvera Inc.
Vancouver, British Columbia--(Newsfile Corp. - February 2, 2018) - The following issues have been halted by IIROC:
Feb 02, 2018 09:09 am ET
IIROC Trading Resumption - NUU
VANCOUVER, Feb. 2, 2018 /CNW/ - Trading resumes in:
Feb 02, 2018 09:02 am ET
IIROC Trading Halt - NUU
VANCOUVER, Feb. 2, 2018 /CNW/ - The following issues have been halted by IIROC:
Feb 01, 2018 05:12 pm ET
Statement from Nuuvera Inc.
TORONTO, Feb. 1, 2018 /CNW/ - In relation to the announced acquisition of the Italian company FL-Group, Nuuvera Inc. ("Nuuvera") (TSXV:NUU) wishes to clarify that the Italian license is held by FL-Group, the wholly owned subsidiary of Nuuvera, and that, according to Italian law, any importation of cannabis products is subject to regulatory approval.
Feb 01, 2018 07:30 am ET
Nuuvera finalizes acquisition of Italian FL-Group
GENOA, Italy, Feb. 1, 2018 /CNW/ - Nuuvera Inc. ("Nuuvera") (TSXV:NUU), announced today that it has closed a transaction to acquire 100% of Genoa based FL-Group. The acquisition, originally announced on January 18, 2018, makes Nuuvera the first Canadian cannabis company to hold a license to serve the Italian market.
Jan 29, 2018 06:00 am ET
Global leader in medical cannabis created by Aphria and Nuuvera combination
Combination capitalizes on Nuuvera's expansive international footprint, expanding network into Europe, Africa and the Middle East
Transaction combines Aphria's low-cost, high quality cultivation at scale with Nuuvera's expertise in cannabis processing, and provides access to Nuuvera's state-of-the-art testing and extraction facilities
Expected be accretive to Aphria shareholders in first full fiscal year after close on an earnings per share basis
Brings together two strong management teams with highly complementary expertise and international relationships
Investment community conference ca
Jan 24, 2018 07:30 am ET
Nuuvera signs letter of intent to acquire GMP-certified lab in Spain
TORONTO, Jan. 24, 2018 /CNW/ - Nuuvera Inc. ("Nuuvera") (TSXV:NUU), is pleased to announce that it has signed a Letter of Intent ("LOI") with Medalchemy S.L. ("Medalchemy") to acquire a majority interest in its fully-licensed, GMP certified laboratory located in Alicante, Spain.
Jan 23, 2018 07:30 am ET
Nuuvera Inc. announces sale agreement for CBD with Tersum S.A.
TORONTO, Jan. 23, 2018 /CNW/ - Nuuvera Inc. ("Nuuvera") (TSXV:NUU), is pleased to announce that ARA-Avanti Rx Analytics Inc. ("Avanti"), a 51% owned subsidiary of Nuuvera, has entered into a Sale Agreement (the "Agreement") with Tersum S.A. ("Tersum"), an Uruguayan licensed producer of cannabis derivatives that is a wholly-owned subsidiary of ICC Labs Inc. (TSXV:ICC).
Jan 19, 2018 07:30 am ET
Nuuvera and Aphria finalize offtake agreement for extra 60,000 kgs of cannabis production
LEAMINGTON, ON, Jan. 19, 2018 /CNW/ - Nuuvera Inc. ("Nuuvera") (TSXV: NUU) and Aphria Inc. ("Aphria") (TSX: APH & US OTC QB: APHQF) announced today that they have executed a previously announced definitive offtake agreement for 60,000 kgs of cannabis production.
Jan 18, 2018 12:04 pm ET
IIROC Trade Resumption - Nuuvera Inc.
Vancouver, British Columbia--(Newsfile Corp. - January 18, 2018) - Trading resumes in:
Jan 18, 2018 11:08 am ET
IIROC Trading Resumption - NUU
VANCOUVER, Jan. 18, 2018 /CNW/ - Trading resumes in:
Jan 18, 2018 10:56 am ET
Nuuvera Inc. Announces Increase to Bought Deal Financing
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/
Jan 18, 2018 09:33 am ET
IIROC Trade Halt - Nuuvera Inc.
Vancouver, British Columbia--(Newsfile Corp. - January 18, 2018) - The following issues have been halted by IIROC:
Jan 18, 2018 08:37 am ET
IIROC Trading Halt - NUU
VANCOUVER, Jan. 18, 2018 /CNW/ - The following issues have been halted by IIROC:
Jan 18, 2018 08:08 am ET
Nuuvera Inc. Announces $35MM Bought Deal Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR
DISSEMINATION IN THE UNITED STATES
Nuuvera Inc. ("Nuuvera" or the "Company") (TSX VENTURE:NUU) is pleased to announce that it has entered into an agreement with Clarus...
Jan 18, 2018 07:37 am ET
Nuuvera Acquires One of Seven Italian Cannabis Licenses
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.
Nuuvera Inc. ("Nuuvera") (TSX VENTURE:NUU), announced today that it has acquired one of only seven licensees to import medical cannabis to Italy,...
Jan 16, 2018 07:30 am ET
/R E P E A T -- Nuuvera and Globalive Technologies partners to bring blockchain to the global cannabis industry in groundbreaking collaboration/
TORONTO, Jan. 16, 2018 /CNW/ - Nuuvera Inc. ("Nuuvera") (TSXV: NUU) is proud to announce it is entering into a joint partnership with Globalive Technology Partners (GTP) to bring blockchain technology to the global cannabis market.
Jan 16, 2018 06:00 am ET
Nuuvera and Globalive Technologies partners to bring blockchain to the global cannabis industry in groundbreaking collaboration
TORONTO, Jan. 16, 2018 /CNW/ - Nuuvera Inc. ("Nuuvera") (TSXV: NUU) is proud to announce it is entering into a joint partnership with Globalive Technology Partners (GTP) to bring blockchain technology to the global cannabis market.
Jan 12, 2018 07:30 am ET
Nuuvera enters MOU to become a supplier for New Brunswick's cannabis market
MOU also lays groundwork for Nuuvera's charitable efforts in the province
Jan 11, 2018 01:10 pm ET
Nuuvera and Aphria Announce Negotiations for an Offtake Agreement
TORONTO, Jan. 11, 2018 /CNW/ - Nuuvera Inc. ("Nuuvera") (TSXV: NUU) and Aphria Inc. ("Aphria") (TSX: APH & US OTC QB: APHQF) announced today that they are in negotiations regarding an offtake agreement.
Jan 11, 2018 07:25 am ET
Isodiol International Inc. Announces Letter of Intent to Import 99%+ Pure Pharma-Grade Cannabidiol to Canada From U.K. With Nuuvera
VANCOUVER, British Columbia, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it...
Jan 11, 2018 06:25 am ET
Nuuvera to Import 99%+ Pharma-Grade Cannabidiol to Canada from U.K.
TORONTO, Jan. 11, 2018 /CNW/ - Nuuvera Inc. ("Nuuvera") (TSXV:NUU) is pleased to announce that it has signed a Letter of Intent ("LOI") with Isodiol International Inc. ("Isodiol") (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F), to import 99%+ pure, bioactive pharma-grade cannabidiol ('CBD') isolate into Canada from Isodiol's GMP-certified production facility in the United Kingdom.
Jan 10, 2018 07:30 am ET
Nuuvera announces the building of a laboratory facility in New Brunswick, Canada
TORONTO, Jan. 10, 2018 /CNW/ - Nuuvera Inc. ("Nuuvera") (TSXV:NUU) is very pleased to announce that it is establishing a state-of-the-art laboratory in Saint John, New Brunswick that will process, manufacture and distribute pharmaceutical-grade medical marijuana derivative products.
Jan 10, 2018 06:25 am ET
Nuuvera enters into marketing and communications partnership with Venture
TORONTO, Jan. 10, 2018 /CNW/ - Today Nuuvera Inc. ("Nuuvera") (TSXV : NUU) announced that it has entered into a marketing and communications partnership with Venture, a marketing agency owned by one of Canada's best-known entrepreneurs, Arlene Dickinson.
Jan 10, 2018 06:20 am ET
Nuuvera Signs Greg Taylor as President of Nuuvera Canada
TORONTO, Jan. 10, 2018 /CNW/ - Nuuvera Inc. ("Nuuvera") (TSXV: NUU) announced today that it has signed Greg Taylor, co-founder of Steam Whistle Brewing, as president of Nuuvera Canada.
Jan 09, 2018 09:36 am ET
IIROC Trade Resumption - Nuuvera Inc.
Vancouver, British Columbia--(Newsfile Corp. - January 9, 2018) - Trading resumes in:
Jan 09, 2018 09:28 am ET
IIROC Trade Halt - Nuuvera Inc.
Vancouver, British Columbia--(Newsfile Corp. - January 9, 2018) - The following issues have been halted by IIROC:
Jan 09, 2018 08:43 am ET
IIROC Trading Resumption - NUU
VANCOUVER, Jan. 9, 2018 /CNW/ - Trading resumes in:
Jan 09, 2018 08:36 am ET
IIROC Trading Halt - NUU
VANCOUVER, Jan. 9, 2018 /CNW/ - The following issues have been halted by IIROC:
Jan 09, 2018 06:25 am ET
Nuuvera shortlisted for cannabis contract with the German Federal Institute for Drugs and Medical Devices
TORONTO, Jan. 9, 2018 /CNW/ - Nuuvera Inc. ("Nuuvera") (TSXV: NUU) has been shortlisted by the German Federal Institute for Drugs and Medical Devices (BfArM) for a contract to grow, process, store and deliver up to 6000 kg of cannabis in Germany.
Jan 09, 2018 06:20 am ET
Nuuvera Germany breaks ground on facility for storage and packaging of medical cannabis
TORONTO, Jan. 9, 2018 /CNW/ - Nuuvera Deutschland GmbH, a wholly-owned subsidiary of Nuuvera Inc. ("Nuuvera") (TSXV: NUU), announced today that it has broken ground on the construction of a storage and packaging facility for medical cannabis products.
Jan 09, 2018 06:15 am ET
Nuuvera enters into letter of intent to export 1,200 kilograms of medical cannabis to Germany
TORONTO, Jan. 9, 2018 /CNW/ - Today Nuuvera Inc. ("Nuuvera") (TSXV: NUU) announced that it has entered into a letter of intent ("LOI") with German pharmaceutical company CC Pharma GmbH to export approximately 1,200 kilograms of medical cannabis products from Canada to Germany.
Jan 08, 2018 04:14 pm ET
IIROC Trade Resumption - Nuuvera Inc.
Vancouver, British Columbia--(Newsfile Corp. - January 8, 2018) - Trading resumes in:
Jan 08, 2018 03:27 pm ET
IIROC Trading Resumption - REQ.H; NUU
VANCOUVER, Jan. 8, 2018 /CNW/ - Trading resumes in:
Jan 07, 2018 01:00 pm ET
Nuuvera to List on TSX Venture Exchange Tuesday January 9th
TORONTO, Jan. 7, 2018 /CNW/ - Due to a clerical error at the TSX, Nuuvera Inc. ("Nuuvera") (TSXV : NUU) was advised by the TSX this morning that it will be open for trading at the market open on Tuesday, January 9, 2018, and not on Monday, January 8, 2018, as previously announced. Nuuvera has been assured by the TSX that the 24-hour delay has been solely caused by the TSX itself and in no way reflects any change in Nuuvera's status as a listed issuer on the TSX Venture Exchange in good standing.
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.